| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $12.8B | $11.9B | $11.1B | $2.7B | $2.6B | $2.6B | $2.6B | $2.3B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | $3.2B | $3.2B | $3.1B | $3.3B | $3.0B |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.9B | $0.8B | $0.6B | $0.3B | $1.4B | $0.4B | $0.4B | $0.0B |
| EPS (Basic) | $17.14 | $14.55 | $12.02 | $1.27 | $2.16 | $2.27 | $2.01 | $0.32 |
| EPS (Diluted) | $16.93 | $14.46 | $11.95 | $1.27 | $2.14 | $2.23 | $1.91 | $0.32 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $36.3B | $35.0B | $33.6B | $33.1B | $33.9B | $44.6B | $44.3B | $41.1B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $1.8B | $1.8B | $1.6B | $1.5B | $2.0B | $2.2B | $1.9B | $1.3B |
| Total Liabilities | $30.4B | $29.9B | $28.8B | $28.9B | $28.4B | $38.7B | $38.6B | $36.0B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $5.9B | $5.1B | $4.8B | $4.2B | $5.5B | $6.0B | $5.7B | $5.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.8B | $1.3B | $1.1B | $0.6B | $0.8B | $1.3B | $1.4B | $0.7B |
| Investing Cash Flow | $-1.5B | $-0.7B | $-0.6B | $-0.3B | $0.2B | $-0.7B | $-0.6B | $-2.2B |
| Capital Expenditures | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $-0.4B | $-0.5B | $-0.4B | $-0.8B | $-1.1B | $-0.3B | $-0.2B | $1.8B |